In patients with multiple myeloma ... bolus-dose cyclophosphamide and pulse-dose dexamethasone (Cy-Dex) as initial treatment for patients with myeloma.

For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not ne ...

Doctors may recommend oral or infused steroid therapy for severe multiple sclerosis flare-ups that impact your functioning. Treatment with ... and weight gain. Dexamethasone can be administered ...

plus the steroid dexamethasone, as well as Bristol Myers Squibb’s Pomalyst (pomalidomide) plus dexamethasone. The application seeks approval for the treatment of multiple myeloma patients who ...

Aspire Pharma (bortezomib, dexamethasone) (confidentiality agreement not signed, not participating) Aurobindo Pharma (bortezomib) (confidentiality agreement not signed, not participating) Bausch & ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients ...

The health ministry has approved the steroid drug ... British clinical trial. Dexamethasone, an anti-inflammatory medication, is the second added to the ministry's treatment guidebook for ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients ...

in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior line of therapy, including lenalidomide ...

London, June 17 () The UK government on Wednesday authorised the state-funded National Health Service (NHS) to use steroid dexamethasone, the "world's first" coronavirus treatment proven to reduce ...